Aquestive Therapeutics CFO John Maxwell's 2020 pay jumps 24% to $1.3M

Aquestive Therapeutics reports 2020 executive compensation

By ExecPay News

Published: May 5, 2021

Aquestive Therapeutics reported fiscal year 2020 executive compensation information on May 5, 2021.
In 2020, three executives at Aquestive Therapeutics received on average a compensation package of $1.1M, a 29% decrease compared to previous year.
Average pay of disclosed executives at Aquestive Therapeutics
John T. Maxwell, Chief Financial Officer, received $1.3M in total, which increased by 24% compared to 2019.
Keith J. Kendall, Chief Executive Officer, received a compensation package of $1.3M, which decreased by 51% compared to previous year. 43% of the compensation package, or $550K, was in salary.
Daniel Barber, Chief Operating Officer, earned $840K in 2020, a 30% decrease compared to previous year.

Related executives

Keith Kendall

Aquestive Therapeutics

Chief Executive Officer

Daniel Barber

Aquestive Therapeutics

Chief Operating Officer

John Maxwell

Aquestive Therapeutics

Chief Financial Officer

You may also like

Source: SEC filing on May 5, 2021.